Bookmarks
UK BioLAM
Population Size
300
People
Years
2004
Associated BioSamples
None/not available
Geographic coverage
United Kingdom
England
Lead time
Data only
Summary
Lymphangioleiomyomatosis (LAM) is a multi-system disease of women. Metabolomics have been used to determine if metabolites downstream of mTOR and other LAM realted pathways were present or related to disease progression in a national cohort.
Documentation
Lymphangioleiomyomatosis (LAM) is a rare lung and lymphatic disease categorised by infiltration of smooth muscle type cells in the lungs and lymphatics leading to progressive respiratory impairment. The disease only effects women and is caused by a defect in one of the two proteins associated with tuberous sclerosis, tuberin and hamartin.
Dataset type
Health and disease
Dataset population size
300
Keywords
Observations
Observed Node | Disambiguating Description | Measured Value | Measured Property | Observation Date |
---|---|---|---|---|
Persons |
| 300 | COUNT | 01 Oct 2004 |
Provenance
Purpose of dataset collection
Study
Biological sample availability
None/not available
Structural Metadata
Details
Publishing frequency
Other
Version
1.0.2
Modified
03/10/2025
Coverage
Start date
01/10/2004
Time lag
Variable
Geographic coverage
United Kingdom, England
Minimum age range
18
Maximum age range
65
Accessibility
Language
en
Alignment with standardised data models
LOCAL
Controlled vocabulary
LOCAL
Format
CSV
Data Access Request
Access service description
Jurisdiction
GB-ENG
Data Controller
Professor Simon Johnson
Data Processor